Epredia completed the acquisition of Microm Microtech France and Laurypath.

Epredia, a biotechnology company that provides labeling, tracking, pathology, cancer diagnostics and tissue diagnostics services, completed the acquisition of Microm Microtech France, an anatomical pathology supplier, and Laurypath, a tissue processing reagents and fixatives manufacturer. Financial terms were not disclosed. “We are pleased to bring MMFrance and Laurypath into PHC Group to contribute to the growth of Epredia’s global business. Our customers in anatomical pathology laboratories need a consistent supply of high-quality diagnostics products, and we are excited to be able to provide a locally manufactured option that eliminates some of the logistical challenges our industry continues to face globally,” Steven Lynum, Epredia President.